References
- Madan A, McMahon JR, Stevenson DK. Neonatal hyperbilirubinemia. In: Taeusch HW, Ballard RA, Gleason CA, Editors. Avery’s Diseases of the Newborn, 8th ed. Philadelphia, Elsevier Saunders, 2005.
- Al-Omran A, Al-Abdi S, Al-Salam Z. Readmission for neonatal hyperbilirubinemia in an area with a high prevalence of glucose-6-phosphate dehydrogenase deficiency: a hospital-based retrospective study. J Neonatal Perinatal Med. 2017; 10(2): 181–189.
- Newman TB, Easterling MJ, Goldman ES, Stevenson DK. Laboratory evaluation of jaundice in newborns. Frequency, cost, and yield. Am J Dis Child. 1990; 144(3): 364–368.
- Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci U S A. 1998; 95(14): 8170–8174.
- Sarici SU, Serdar MA, Korkmaz A, Erdem G, Oran O, Tekinalp G, et al. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics. 2004; 113(4): 775–780.
- Mei H, Dong X, Wu B, Wang H, Lu Y, Hu L, et al. Clinical and genetic etiologies of neonatal unconjugated hyperbilirubinemia in the china neonatal genomes project. J Pediatr. 2022 Apr; 243: 53–60.e9.
- Bhutani VK, Johnson LH, Sivieri EM. Universal newborn bilirubin screening. Pediatr Res. 1997; 41: 191.
- Watchko JF, Lin Z. Exploring the genetic architecture of neonatal hyperbilirubinemia. Semin Fetal Neonatal Med. 2010; 15(3): 169–175.
- Liu W, Chang LW, Xie M, Li WB, Rong ZH, Wu L, et al. Correlation between UGT1A1 polymorphism and neonatal hyperbilirubinemia of neonates in Wuhan. J Huazhong Univ Sci Technolog Med Sci. 2017; 37(5): 740–743.
- Wang J, Yin J, Xue M, Lyu J, Wan Y. Roles of UGT1A1 Gly71Arg and TATA promoter polymorphisms in neonatal hyperbilirubinemia: A meta-analysis. Gene. 2020; 736: 144409.
- Kilic I, Koseler A, Cakaloz I, Atalay E. Screening for G71R mutation of the UDP-glucuronosyltransferase 1 (UGT1A1) gene in neonates with pathologic and prolonged hyperbilirubinemia in Turkey. Int J Clin Pharmacol Ther. 2010; 48(8): 504–548.
- Narter F, Can G, Ergen A, Isbir T, Ince Z, Çoban A. Neonatal hyperbilirubinemia and G71R mutation of the UGT1A1 gene in Turkish patients. J Matern Fetal Neonatal Med. 2011; 24(2): 313–316.
- Yang H, Wang Q, Zheng L, Lin M, Zheng XB, Lin F, et al. Multiple genetic modifiers of bilirubin metabolism involvement in significant neonatal hyperbilirubinemia in patients of Chinese descent. PLoS One. 2015; 10(7): e0132034.
- D’Silva S, Colah RB, Ghosh K, Mukherjee MB. Combined effects of the UGT1A1 and OATP2 gene polymorphisms as major risk factor for unconjugated hyperbilirubinemia in Indian neonates. Gene. 2014; 547(1): 18–22.
- Wong F, Boo N, Othman A. Risk factors associated with unconjugated neonatal hyperbilirubinemia in Malaysian neonates. J Trop Pediatr. 2013; 59(4): 280–285.
- Huang MJ, Kua KE, Teng HC, Tang KS, Weng HW, Huang CS. Risk factors for severe hyperbilirubinemia in neonates. Pediatr Res. 2004; 56(5): 682–689.
- Liu J, Long J, Zhang S, Fang X, Luo Y. The impact of SLCO1B1 genetic polymorphisms on neonatal hyperbilirubinemia: a systematic review with meta-analysis. J Pediatr (Rio J). 2013; 89(5): 434–443.
- Büyükkale G, Turker G, Kasap M, Akpınar G, Arısoy E, Günlemez A, et al. Neonatal hyperbilirubinemia and organic anion transporting polypeptide-2 gene mutations. Am J Perinatol. 2011; 28(8): 619–626.
- Alencastro de Azevedo L, Reverbel da Silveira T, Carvalho CG, Martins de Castro S, Giugliani R, Matte U. UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms vs. neonatal hyperbilirubinemia: is there an association? Pediatr Res. 2012; 72(2): 169–173.
- Watchko JF, Lin Z, Clark RH, Kelleher AS, Walker MW, Spitzer AR; Pediatrix Hyperbilirubinemia Study Group. Complex multifactorial nature of significant hyperbilirubinemia in neonates. Pediatrics. 2009; 124(5): e868–877.
- Prachukthum S, Nunnarumit P, Pienvichit P, Chuansumrit A, Songdej D, Kajanachumpol S, et al. Genetic polymorphisms in Thai neonates with hyperbilirubinemia. Acta Paediatr. 2009; 98(7): 1106–1110.
- Al-Abdi SY. Decreased Glutathione S-transferase level and neonatal hyperbilirubinemia associated with glucose-6-phosphate dehydrogenase deficiency: A perspective review. Am J Perinatol. 2017; 34(3): 305–314.
- Madlon-Kay DJ. The clinical significance of ABO blood group incompatibility. Arch Fam Med. 1993; 2(3): 285–287.
- Muslu N, Dogruer ZN, Eskandari G, Atici A, Kul S, Atik U. Are glutathione S-transferase gene polymorphisms linked to neonatal jaundice? Eur J Pediatr. 2008; 167(1): 57–61.